← Open Payments lookup

REBECCA ELLEN: Open Payments

NPI 1962740407 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$733 in 31 payments from 13 companies in 2025. Trend: 2023 $755 · 2024 $993 · 2025 $733

Food & beverage: $733
CompanyPaymentsAmount
ABBVIE INC.5$121
Neurocrine BioSciences, Inc.4$117
Vanda Pharmaceuticals Inc.4$109
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$78
Alkermes, Inc.3$56
Axsome Therapeutics, Inc.2$48
Otsuka America Pharmaceutical, Inc.2$42
E.R. Squibb & Sons, L.L.C.2$40
Janssen Pharmaceuticals, Inc1$36
Takeda Pharmaceuticals U.S.A., Inc.2$36

Products named: VRAYLAR, INGREZZA, HETLIOZ, CAPLYTA, REXULTI, Auvelity, COBENFY, ARISTADA.

Industry payments across MD — which companies pay providers there.